These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38668435)

  • 1. Correlation between 146S Antigen Content in Foot-and-Mouth Disease Inactivated Vaccines and Immunogenicity Level and Vaccine Potency Alternative Test Methods.
    Li Y; Yang R; Yin F; Zhang H; Zhai G; Sun S; Tian B; Zeng Q
    Vet Sci; 2024 Apr; 11(4):. PubMed ID: 38668435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunopotentiator CVC1302 enhances immune efficacy and protective ability of foot-and-mouth disease virus vaccine in pigs.
    Chen J; Yu X; Zheng Q; Hou L; Du L; Zhang Y; Qiao X; Hou J; Huang K
    Vaccine; 2018 Dec; 36(52):7929-7935. PubMed ID: 30470640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BacMam Expressing Highly Glycosylated Porcine Interferon Alpha Induces Robust Antiviral and Adjuvant Effects against Foot-and-Mouth Disease Virus in Pigs.
    Kim A; Lee G; Hwang JH; Park JH; Lee MJ; Kim B; Kim SM
    J Virol; 2022 Jun; 96(12):e0052822. PubMed ID: 35604219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Using size-exclusion chromatography to quantify the 146S antigen in inactivated foot-and-mouth disease vaccine].
    Xu Y; Zou X; Li C; Zhu Y; He T; Yang Y; Lin X; Song Y; Zheng J; Zhang S; Zhao Q
    Sheng Wu Gong Cheng Xue Bao; 2018 May; 34(5):676-684. PubMed ID: 29893075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of chemical extraction methods for determination of 146S content in foot-and-mouth disease oil-adjuvanted vaccine.
    Saravanan P; Iqbal Z; Selvaraj DPR; Aparna M; Umapathi V; Krishnaswamy N; Tamilselvan RP
    J Appl Microbiol; 2020 Jan; 128(1):65-73. PubMed ID: 31562676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of novel inactivated vaccine for type C foot-and-mouth disease in cattle and pigs.
    You SH; Jo HE; Choi JH; Ko MK; Shin SH; Lee MJ; Kim SM; Kim B; Park JH
    Vet Microbiol; 2019 Jul; 234():44-50. PubMed ID: 31213271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of Single-Domain Antibody Fragments That Preferentially Detect Intact (146S) Particles of Foot-and-Mouth Disease Virus for Use in Vaccine Quality Control.
    Harmsen MM; Seago J; Perez E; Charleston B; Eblé PL; Dekker A
    Front Immunol; 2017; 8():960. PubMed ID: 28861080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative Detection of the Foot-And-Mouth Disease Virus Serotype O 146S Antigen for Vaccine Production Using a Double-Antibody Sandwich ELISA and Nonlinear Standard Curves.
    Feng X; Ma JW; Sun SQ; Guo HC; Yang YM; Jin Y; Zhou GQ; He JJ; Guo JH; Qi SY; Lin M; Cai H; Liu XT
    PLoS One; 2016; 11(3):e0149569. PubMed ID: 26930597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of viral particle integrity in the serological assessment of foot-and-mouth disease virus vaccine-induced immunity in swine.
    Mansilla FC; Turco CS; Miraglia MC; Bessone FA; Franco R; Pérez-Filgueira M; Sala JM; Capozzo AV
    PLoS One; 2020; 15(5):e0232782. PubMed ID: 32369529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vaccine pretreatment for quantification of 146S antigen in foot-and-mouth disease vaccines by high performance size exclusion chromatography].
    Song Y; Yang Y; Su Z; Liu L; Zhu Y; Xu Y; Zou X; Zhao Q; Zhang S
    Sheng Wu Gong Cheng Xue Bao; 2019 Aug; 35(8):1441-1452. PubMed ID: 31441615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cell density on the biological titer and yield of 146S fraction of foot-and-mouth disease virus O in cell suspension.
    Rizvi A; Hussain N; Anjum AA; Ahmed N; Naeem A; Khan M; Altaf I
    J Virol Methods; 2022 Feb; 300():114379. PubMed ID: 34826516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant effect of saponin in an oil-based monovalent (serotype O) foot-and-mouth disease virus vaccine on the antibody response in guinea pigs and cattle.
    Bazid AI; El-Alfy HA; El-Didamony G; Elfeil WK; El-Sayed MM; Fawzy M
    Arch Virol; 2021 Jul; 166(7):1977-1984. PubMed ID: 33871696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and efficacy evaluation of a novel water-in-oil-in-water adjuvant for an inactivated foot-and-mouth disease vaccine.
    Zhang R; Wei Y; Liu X; Wu Y
    Pharm Dev Technol; 2024 Feb; 29(2):75-85. PubMed ID: 38217108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermostable negative-marker foot-and-mouth disease virus serotype O induces protective immunity in guinea pigs.
    Ranjitha HB; Dhanesh VV; Hosamani M; Sreenivasa BP; Jabeen U; Biswal JK; Saravanan P; Sanyal A; Bhanuprakash V; Basagoudanavar SH
    Appl Microbiol Biotechnol; 2023 Feb; 107(4):1285-1297. PubMed ID: 36656322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with foot-and-mouth disease virus of O/SEA/Mya-98 lineage in sheep.
    Singanallur NB; Pacheco JM; Arzt J; Stenfeldt C; Fosgate GT; Rodriguez L; Vosloo W
    Antiviral Res; 2017 Sep; 145():114-122. PubMed ID: 28780422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Layered double hydroxide nanoparticles as an adjuvant for inactivated foot-and-mouth disease vaccine in pigs.
    Wu P; Zhang Y; Yin X; He Y; Zhang Q; Chen C
    BMC Vet Res; 2020 Dec; 16(1):474. PubMed ID: 33276787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokine CCL20 plasmid improves protective efficacy of the Montanide ISA™ 206 adjuvanted foot-and-mouth disease vaccine in mice model.
    Jayeshbhai C; Hajam IA; Verma AK; Bhanuprakash V; Kondabattula G; Kishore S
    Vaccine; 2018 Aug; 36(35):5318-5324. PubMed ID: 30054161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xylaria hypoxylon Lectin as Adjuvant Elicited Tfh Cell Responses.
    Kang J; Zuo Y; Guo Q; Wang H; Liu Q; Liu Q; Xia G; Kang Y
    Scand J Immunol; 2015 Nov; 82(5):436-42. PubMed ID: 26289530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-protective efficacy of engineering serotype A foot-and-mouth disease virus vaccine against the two pandemic strains in swine.
    Zheng H; Lian K; Yang F; Jin Y; Zhu Z; Guo J; Cao W; Liu H; He J; Zhang K; Li D; Liu X
    Vaccine; 2015 Oct; 33(43):5772-5778. PubMed ID: 26431990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of FMD type A87/IRN inactivated vaccine by gamma irradiation and the immune response on guinea pig.
    Sedeh FM; Khorasani A; Shafaee K; Fatolahi H; Arbabi K
    Indian J Microbiol; 2008 Sep; 48(3):326-30. PubMed ID: 23100729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.